Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled
Go back to Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled| Pfizer Inc. (NYSE: PFE) | Delayed: 28.54 -0.18 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.72 | 52 Week High | $37.39 | |||
| Open | $28.60 | 52 Week Low | $28.25 | |||
| Day High | $28.76 | P/E | 17.30 | |||
| Day Low | $28.45 | EPS | $1.65 | |||
| Volume | 3,035,704 | |||||
